Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-26-056540
Filing Date
2026-05-06
Accepted
2026-05-06 21:32:48
Documents
1
Period of Report
2026-05-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2613874-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2613874-2_4seq1.xml 4 10467
  Complete submission text file 0001104659-26-056540.txt   12665
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Issuer) CIK: 0001739410 (see all company filings)

EIN.: 851083789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ANEBULO PHARMACEUTICALS, INC. 1415 RANCH ROAD 620 SOUTH, SUITE 201 LAKEWAY TX 78734
Business Address
Schneeberger Daniel (Reporting) CIK: 0001861120 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40693 | Film No.: 26950484

Mailing Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738
Business Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738 512-254-3790
ADAR1 Capital Management, LLC (Reporting) CIK: 0001940272 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40693 | Film No.: 26950485